These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17274593)

  • 21. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
    Roc AC; Ances BM; Chawla S; Korczykowski M; Wolf RL; Kolson DL; Detre JA; Poptani H
    Arch Neurol; 2007 Sep; 64(9):1249-57. PubMed ID: 17620480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
    Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
    AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy.
    Palacios R; Santos J; González M; Ruiz J; Márquez M
    Int J STD AIDS; 2007 Mar; 18(3):184-7. PubMed ID: 17362552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality after myocardial infarction in HIV-infected patients who have initiated HAART.
    Rasmussen LD; Gerstoft J; Kronborg G; Larsen CS; Pedersen G; Obel N
    AIDS; 2007 Apr; 21(7):873-5. PubMed ID: 17415045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-infections. Can hepatitis C virus help keep cholesterol levels low?
    TreatmentUpdate; 2006; 18(5):4-5. PubMed ID: 17205648
    [No Abstract]   [Full Text] [Related]  

  • 29. Andractim for HAART-associated breast enlargement.
    TreatmentUpdate; 2001 Sep; 13(5):6. PubMed ID: 11768864
    [No Abstract]   [Full Text] [Related]  

  • 30. Severe gynecomastia in an African boy with perinatally acquired human immunodeficiency virus infection receiving highly active antiretroviral therapy.
    Dzwonek A; Clapson M; Withey S; Bates A; Novelli V
    Pediatr Infect Dis J; 2006 Feb; 25(2):183-4. PubMed ID: 16462304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical impacts of highly active antiretroviral therapy on patients of hemophilia combined with acquired immunodeficiency syndrome: 6-year follow-up of 39 cases].
    Dai ZS; Zhang XX; Wang JR; Zhang YJ; Sun HQ; Lu HZ
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):872-5. PubMed ID: 19671284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitor development and successful immune tolerance in an HIV-infected patient with haemophilia A and after immune reconstitution with HAART.
    Kruse-Jarres R; Hadi CM; Leissinger CA
    Haemophilia; 2007 Nov; 13(6):707-11. PubMed ID: 17973846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient bone marrow oedema syndrome in an HIV-infected patient on highly active antiretroviral therapy.
    Vera JH; Walker AE; Kinderlerer A; Cooke GS
    Int J STD AIDS; 2012 Mar; 23(3):213-5. PubMed ID: 22581878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gynaecomastia in HIV-infected men: association with effects of antiretroviral therapy.
    Paech V; Lorenzen T; von Krosigk A; Graefe K; Stoehr A; Plettenberg A
    AIDS; 2002 May; 16(8):1193-5. PubMed ID: 12004284
    [No Abstract]   [Full Text] [Related]  

  • 35. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
    Michel L; Giorgi R; Villes V; Poizot-Martin I; Dellamonica P; Spire B; Protopopescu C; Carrieri MP
    Drug Alcohol Depend; 2009 Jan; 99(1-3):96-104. PubMed ID: 18774237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART).
    Bansil P; Jamieson DJ; Posner SF; Kourtis AP
    J Womens Health (Larchmt); 2007 Mar; 16(2):159-62. PubMed ID: 17388731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cutaneous drug reactions in HIV-infected patients in the HAART era].
    Blanes M; Belinchón I; Portilla J
    Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
    Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
    Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A frontal mucocele caused by an immune reconstitution inflammatory syndrome in a patient with HIV infection.
    Colebunders B; Claes G; Vlieghe E; Demeester R; Moerman F; Colebunders R
    Rhinology; 2008 Sep; 46(3):243-5. PubMed ID: 18853879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
    Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
    AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.